GVR Report cover Urology Surgical Instruments Market Report

Urology Surgical Instruments Market Analysis Report By Product (Endoscopes, Endovision Systems, Peripheral Systems, Consumables & Accessories), By Application (CKD, Urinary Stones, Oncology), And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-2-68038-323-2
  • Number of Pages: 165
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2015
  • Industry: Healthcare

Report Overview

The global urology surgical instruments market size was valued at USD 7.27 billion in 2016 and is projected to expand at a CAGR of 7.9% during the forecast period. Some of the key factors responsible for the growth of the market are rising geriatric population, increasing prevalence of urinary disorders, growing preference for minimally invasive surgeries, surging expenditure on R&D, and ongoing product launches by manufacturers. 

U.S. urology surgical instruments market size

The geriatric population is considered to be more susceptible to digestive disorders, incontinence, and chronic conditions, which require long-term care. Hence, a rise in the global geriatric population is expected to serve as a high impact rendering driver. The rise in geriatric population will also increase the number of surgeries performed. Advancing technologies, improving healthcare delivery services, and an overall improvement in the quality of life is contributing to the increasing life expectancy of people around the world.

In recent years, there has also been an increase in the incidence of chronic kidney disease (CKD) among the elderly population across the globe. According to National Health and Nutrition Examination Survey (NHANES) and National Kidney Foundation, about 12.1% of males suffer from CKD in the U.S. The data also states that in 2013, more than 57.7% of new end-stage renal diseases or kidney failure cases occurred in men. About 57.3% of patients receiving treatment for kidney failure in the U.S. are male. NHANES data states that about 15.1% of women suffer from CKDs. This alarming rise in patients suffering from urinary dysfunctions results in a greater need for urology procedures, thereby fueling demand for surgical instruments.

Many manufacturers have been investing in R&D for the development of new and technologically advanced products in the past few years. For instance, in FY 2017, the research and development expenses of Olympus Corporation stood at USD 355.21 million. Similarly, the R&D costs of Coloplast in 2016/17 were nearly USD 94.08 million (DKK 574 million). This has increased from USD 83.43 million (DKK 509 million) in 2015/16. These R&D investments aid in the development and launch of new products in the market. For instance, in February 2017, Cook Medical launched Universa sets for percutaneous urinary drainage. These are available in different sizes to meet patients’ needs and preferences.

Product Insights

Based on the type of product, the market is segmented into endoscopes, envision systems, peripheral systems, and consumables, and accessories. In 2016, the consumables and accessories segment held the largest share in the market; the segment is also anticipated to grow at the highest rate during the forecast period.

Repeated usage of these products and their disposable nature are major factors driving this segment. Also, a global rise in the number of urology procedures is expected to boost the demand for these products in the coming years. Consumables and accessories are further segmented into stone baskets/retrieval devices and extractors, fluid flushing devices, stents, needle forceps, and needle holders, drainage bags, clamps, biopsy devices, connecting tubes, distal attachments, overtures, catheters, dilator sets, and ureteral access sheaths, guidewires, surgical dissectors, and others. In 2016, guidewires held the largest share in the consumables and accessories segment and are expected to exhibit a strong CAGR during the forecast period.

In 2016, endoscopes held the second-largest share in the market by product. Increasing demand for minimally invasive techniques in diagnostics and therapeutics is a key factor driving the urology endoscopes market. Furthermore, the rise in investments by private players, increase in grants or funds by the public sector, and a surge in the number of hospitals and clinics are factors expected to boost demand for endoscopes over the forecast period.

Application Insights

Based on application, the urology surgical instruments market is segmented into chronic kidney diseases (CKD), benign prostatic hyperplasia (BPH), urinary stones, urinary incontinence (UI) and pelvic organ prolapse (POP), oncology, and others. In 2016, the chronic kidney disease segment held the largest share in the market. This can be attributed to the rising incidence of CKD, an increasing number of clinical trials for new non-invasive procedures to treat these diseases, and initiatives by governments across the globe. According to the National Chronic Kidney Disease Fact Sheet, 2017 published by CDC, nearly 30 million adults, or 15% of the U.S. population, had CKD as of 2014. Also, as many as 118,000 people in the country started treatment for ESRD in 2014 and 662,000 were living on chronic dialysis or with a kidney transplant in the same year.

The urinary incontinence and pelvic organ prolapse segment are anticipated to exhibit the highest growth rate during the forecast period. This is due to a significant increase in the number of surgical procedures for urinary incontinence, growing awareness about incontinence, advancing technologies, and rising adoption of these products for managing incontinence. Also, a rise in the number of surgical procedures for POP is expected to boost the demand for urology surgical instruments in the coming years.

Regional Insights

In 2016, North America dominated the global market with a share of 41.5%. Growing geriatric population in U.S. and Canada, rising incidences of urology cancers and disorders, increasing urology equipment purchases by hospitals, rise in several urologists, positive reimbursement scenario, and increasing healthcare spending on urology disorders are some of the key factors likely to boost the regional market for urology surgical instruments during the forecast period.

Global urology surgical instruments market share

The U.S. is one of the key markets in the region and growth can be attributed to the presence of large patient populations with urinary disorders, rising number of urology procedures, increasing hospital expenditure on the purchase of urology surgical instruments, and incessant launch of technologically advanced products. Also, availability of reimbursement for urology procedures is expected to boost the number of urology procedures conducted, and therefore demand for associated instruments, in the coming years.

The Asia Pacific market is anticipated to exhibit the highest CAGR of 8.4% over the forecast period. Rise in free trade agreements between Asian countries and western countries, increasing healthcare expenditure for urology by governments, stringent regulatory policies for usage of invasive devices, improving healthcare infrastructure in China and India, and rapid growth of medical tourism are expected to bolster market growth in the coming years. Also, a large number of private and public hospitals in China, Australia, New Zealand, Malaysia, Singapore, Japan, Indonesia, and India are purchasing new urology equipment to meet the rising demand for urology procedures.

Urology Surgical Instruments Market Share Insights

Some of the key market players are Olympus Corporation, Coloplast Group, Richard Wolf GmbH, KARL STORZ, Cook, Boston Scientific Corporation, Medtronic, Teleflex Incorporated, and Stryker. Technological innovations, new product launches, and partnerships are some of the key strategies adopted by these players to gain a competitive edge.

Urology Surgical Instruments Market Report Scope

Report Attribute


The market size value in 2020

USD 9.3 billion

The revenue forecast in 2025

USD 14.1 billion

Growth Rate

CAGR of 7.9% from 2017 to 2025

The base year for estimation


Historical data

2014 – 2015

Forecast period

2017 – 2025

Quantitative units

Revenue in USD million and CAGR from 2017 to 2025

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Segments covered

Product, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; Japan; China; Brazil; Mexico; South Africa

Key companies profiled

Olympus Corporation; Coloplast Group; Richard Wolf GmbH; KARL STORZ; Cook; Boston Scientific Corporation; Medtronic; Teleflex Incorporated; Stryker

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the global urology surgical instruments market report based on product, application, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Endoscopes

      • Laparoscopes

      • Ureteroscopes

      • Nephroscopes

      • Resectoscopes

      • Cystoscopes

    • Envision Systems

      • Light Sources

      • Cameras

      • Camera Heads

      • Monitors & Displays

    • Peripheral Systems

      • Insufflators

      • Endoscopy Fluid Flushing Devices

    • Consumables & Accessories

      • Guidewires

      • Stone Baskets/Retrieval Devices and Extractors

      • Catheters

      • Stents

      • Biopsy Devices

      • Fluid Flushing Devices, Connecting Tubes, Clamps, Overtubes, and Distal Attachments

      • Dilator Sets and Ureteral Access Sheaths

      • Drainage Bags

      • Surgical Dissectors

      • Needle Forceps and Needle Holders

      • Others

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Chronic Kidney Diseases (CKD)

    • Benign Prostatic Hyperplasia (BPH)

    • Urinary Stones

    • Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)

    • Oncology

    • Other Applications

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon